arrow
A

Antònia Sampol

Hospital Universitari Son Espases
H指数:25
被引数:2,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis

GVHD的预防与发生情况:当代alloHSCT下的大规模真实世界GETH/TC分析

2026-09-170
PRE
Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge

病例报告:伴有中枢神经系统浸润的儿科急性髓系白血病病例,其具有混合免疫表型特征和TCF3::ZNF384融合,为诊断和治疗带来了挑战

2026-05-010
PRE
Frequency and Distribution of KIR Genotypes of Donors-Recipient Pairs in the Haploidentical Haematopoietic Stem Cell Transplantation Setting: Collaborative Study by the Spanish Working Group in Histocompatibility and Transplant Immunology (GETHIT) and the Spanish Haematopoietic Transplantation and Cell Therapy Group (GETH-TC)

供者-受者对在单倍相合造血干细胞移植中的KIR基因型频率和分布:西班牙组织相容性和移植免疫学工作组(GETHIT)与西班牙造血干细胞移植和细胞治疗工作组(GETH-TC)的协作研究

HLA
IF4.1
2025-05-210
PRE
High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy

新诊断多发性骨髓瘤早期复发的危险因素:细胞遗传学和初始治疗反应的影响

2025-04-240
OAAI
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

自体干细胞移植治疗复发/难治性大B细胞淋巴瘤:一项多中心GETH-TC/GELTAMO研究

2025-04-030
OA
Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation Trials

t(11;14)是否总是一种标准风险细胞遗传学异常?GEM05MENOS65和GEM2012 PETHEMA/GEM移植试验的结果。

2025-01-250
PRE
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease

新诊断的移植不合格的多发性骨髓瘤患者的免疫麻痹恢复,这是补充最小残留疾病的独立预后因素

2024-10-230
PRE
Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting
2024-07-040
OAAI
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
2024-01-110
OAAI
Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party
2024-01-013
OAAI
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection

在新诊断的符合移植条件的骨髓瘤患者中恢复未涉及的重链/轻链对免疫麻痹,补充了微小残留病检测的预后价值

2023-11-304
OAAI
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
2023-05-266
OAAI
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
2023-05-056
OAAI
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
2023-01-202
OAAI
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
2022-04-1911
OAAI
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC
2022-04-0114
OAAI